Effects of Pediococcus acidilactici on growth, blood physiology, health and gene expression in red tilapia.
- 2025-11-25
- AMB Express 15(1)
- PubMed: 41288812
- DOI: 10.1186/s13568-025-01954-x
Study Design
- Type
- Clinical Trial
- Sample size
- n = 180
- Population
- 180 tilapia fingerlings (average weight 17.10 ± 0.46 g) red tilapia (Oreochromis niloticus × O. mossambicus)
- Methods
- Fish were distributed into four groups and fed a basal diet supplemented with 0 (PCA0), 1 (PCA1), 2 (PCA2), and 3 (PCA3) g of Pediococcus acidilactici per kg of diet for 63 days; then challenged with the bacterial pathogen Aeromonas hydrophila
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|---|---|---|---|---|
| Pediococcus acidilactici | — | Enhanced Disease Resistance | Beneficial | Large | View sourceFollowing pathogen challenge, the survival rate was significantly higher in all PCA-supplemented groups compared to the control group, with the highest survival observed in the PCA3 group. |
| Pediococcus acidilactici | — | Improved Body Composition | Beneficial | Moderate | View sourcebody composition analysis showed a statistically significant increase in protein and ash content, accompanied by a statistically significant decrease in lipid content (P<0.05). |
| Pediococcus acidilactici | — | Improved Growth Performance | Beneficial | Large | View sourceFish fed diets having 2 or 3 PCA had superior FBW, SGR, and ADG, while these levels significantly improved the FCR compared to the untreated diet (P<0.001). |
| Pediococcus acidilactici | — | Improved Hematological Health | Beneficial | Moderate | View sourceNotable improvements in hematological variables and blood protein fractions were observed in the PCA2 and PCA3 groups compared to other groups (P<0.05). |
| Pediococcus acidilactici | — | Improved Immune Function | Beneficial | Large | View sourceDietary PCA significantly enhanced phagocytic index, and serum IgG and IgM levels in a dose-dependent response. |